Wellgistics Health, Inc. (WGRX)

Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products, including generic and branded pharmaceuticals, to manufacturers and independent retail pharmacies in the United States. The company also offers third-party logistics services and operates the DelivMeds platform, a pharmaceutical hub with clinical concierge services.

44/100 AI Score MCap 29M Vol 256K

Company Overview

CEOPrashant Patel
Employees31
HeadquartersTampa, FL, US
IPO Year2025

Wellgistics Health, Inc. is a pharmaceutical distributor leveraging its DelivMeds platform and third-party logistics to connect manufacturers and independent pharmacies, offering a comprehensive solution in a fragmented market, but faces profitability challenges with a negative profit margin of -1300.3%.

Investment Thesis

Wellgistics Health, Inc. presents a speculative investment opportunity, primarily driven by its DelivMeds platform and third-party logistics services, which aim to streamline pharmaceutical distribution for independent pharmacies and manufacturers. The company's focus on this niche market could provide a competitive edge. However, the company's financial performance raises concerns, given its negative profit margin of -1300.3% and negative P/E ratio of -0.32. The company's high beta of -8.54 suggests high volatility. Successful execution of its growth strategies, particularly expanding the DelivMeds platform and improving operational efficiency, is crucial for realizing value. Investors should closely monitor the company's ability to achieve profitability and manage its cash flow effectively.

Key Highlights

  • Market capitalization of $0.02 billion, indicating a small-cap company with potential for growth but also higher risk.
  • Negative P/E ratio of -0.32, reflecting current losses and the need for improved profitability.
  • Profit margin of -1300.3%, highlighting significant challenges in cost management and revenue generation.
  • Gross margin of 4.1%, indicating a narrow margin for covering operating expenses and achieving profitability.
  • Beta of -8.54, suggesting an inverse correlation with the market and potentially lower volatility during market downturns, but also limited upside during market rallies.

Competitors

Strengths

  • DelivMeds platform offers a unique value proposition.
  • Focus on independent pharmacies creates a niche market.
  • Integrated third-party logistics services provide comprehensive solutions.
  • Strategic location in Tampa, Florida.

Weaknesses

  • Negative profit margin indicates financial instability.
  • Small market capitalization limits access to capital.
  • High beta suggests volatile stock performance.
  • Limited operating history as Wellgistics Health, Inc.

Catalysts

  • Upcoming: Expansion of the DelivMeds platform to new geographic regions by Q4 2026, potentially increasing revenue and market share.
  • Ongoing: Strategic partnerships with small to mid-size pharmaceutical manufacturers, enhancing product offerings and distribution capabilities.
  • Ongoing: Development of specialized third-party logistics services, attracting high-value clients and increasing revenue.

Risks

  • Potential: Negative profit margin and limited cash reserves could hinder growth and operations.
  • Potential: Competition from larger, more established pharmaceutical distributors could erode market share.
  • Potential: Regulatory changes in the pharmaceutical industry could increase compliance costs.
  • Ongoing: Dependence on the DelivMeds platform for growth creates a single point of failure.

Growth Opportunities

  • Expansion of DelivMeds Platform: Wellgistics Health can capitalize on the growing need for streamlined prescription management and clinical support services among independent pharmacies. By expanding the DelivMeds platform's reach and functionality, the company can attract more pharmacies to its network, increasing transaction volume and generating recurring revenue. The market for pharmaceutical hub services is estimated to reach $5 billion by 2028, providing a significant growth runway for Wellgistics Health.
  • Strategic Partnerships with Manufacturers: Forming strategic alliances with small to mid-size pharmaceutical manufacturers can enhance Wellgistics Health's product offerings and distribution capabilities. By becoming a preferred distributor for these manufacturers, the company can secure a consistent supply of products and gain access to exclusive distribution rights. The market for third-party logistics in the pharmaceutical industry is projected to grow to $120 billion by 2027, creating opportunities for Wellgistics Health to expand its logistics services.
  • Geographic Expansion: Wellgistics Health can expand its geographic footprint by targeting underserved markets and regions with a high concentration of independent pharmacies. By establishing distribution centers in strategic locations, the company can reduce shipping costs and improve delivery times, enhancing its competitiveness. The market for pharmaceutical distribution in the United States is estimated at $500 billion annually, offering ample opportunities for growth through geographic expansion.
  • Enhancement of Third-Party Logistics Services: Wellgistics Health can further develop its third-party logistics services by offering specialized solutions such as temperature-controlled storage and transportation for sensitive pharmaceutical products. By catering to the unique needs of pharmaceutical manufacturers, the company can differentiate itself from competitors and attract high-value clients. The market for cold chain logistics in the pharmaceutical industry is expected to reach $20 billion by 2025, presenting a lucrative growth opportunity.
  • Acquisition of Smaller Distributors: Wellgistics Health can pursue strategic acquisitions of smaller pharmaceutical distributors to consolidate its market position and expand its customer base. By acquiring companies with complementary product offerings or geographic coverage, Wellgistics Health can achieve economies of scale and enhance its overall competitiveness. The pharmaceutical distribution industry is highly fragmented, offering numerous acquisition opportunities for Wellgistics Health to pursue.

Opportunities

  • Expansion of DelivMeds platform to new markets.
  • Strategic partnerships with pharmaceutical manufacturers.
  • Acquisition of smaller pharmaceutical distributors.
  • Increased demand for third-party logistics services in the pharmaceutical industry.

Threats

  • Competition from larger, more established pharmaceutical distributors.
  • Regulatory changes in the pharmaceutical industry.
  • Economic downturn affecting healthcare spending.
  • Potential cybersecurity threats to the DelivMeds platform.

Competitive Advantages

  • DelivMeds Platform: Provides a unique technology platform that streamlines prescription transfers and offers clinical concierge services, creating a competitive advantage.
  • Focus on Independent Pharmacies: Specializes in serving the needs of independent pharmacies, building strong relationships and loyalty.
  • Third-Party Logistics Services: Offers integrated logistics solutions, providing value-added services to pharmaceutical manufacturers.
  • Specialty Retail Community: Operates a retail community specialty, further expanding its reach within the pharmaceutical landscape.

About

Wellgistics Health, Inc., formerly known as Danam Health, Inc., was incorporated in 2022 and is based in Tampa, Florida. The company underwent a name change in October 2024, signaling a strategic shift in its business operations. Wellgistics Health operates as a wholesaler and distributor of pharmaceutical products, catering to both pharmaceutical manufacturers and independent retail pharmacies across the United States. Its core business involves the distribution of a wide range of pharmaceutical products, including generic and branded medications, as well as over-the-counter healthcare and consumer products. Beyond traditional distribution, Wellgistics Health offers comprehensive third-party logistics services, encompassing warehousing, inventory management, pick and pack operations, and shipping solutions tailored for small and mid-size pharmaceutical manufacturers. A key differentiator for Wellgistics Health is its DelivMeds platform. This platform functions as a pharmaceutical hub, streamlining the transfer of prescriptions and providing backend clinical concierge services to a network of independent pharmacies. The company also operates a retail community specialty, further expanding its reach within the pharmaceutical landscape. Wellgistics Health's integrated approach aims to provide a seamless and efficient supply chain solution for its clients.

What They Do

  • Wholesales and distributes generic pharmaceuticals to independent retail pharmacies.
  • Distributes branded pharmaceuticals to independent retail pharmacies.
  • Provides over-the-counter healthcare and consumer products to pharmacies.
  • Offers warehousing and inventory management services to pharmaceutical manufacturers.
  • Provides pick and pack services for pharmaceutical manufacturers.
  • Offers shipping services to small and mid-size pharmaceutical manufacturers.
  • Operates the DelivMeds platform, a pharmaceutical hub for prescription transfers.
  • Provides backend clinical concierge services to independent pharmacies through DelivMeds.

Business Model

  • Generates revenue through the sale of pharmaceutical products to independent retail pharmacies.
  • Earns fees for providing third-party logistics services to pharmaceutical manufacturers.
  • Collects fees from pharmacies for using the DelivMeds platform and its clinical concierge services.

Industry Context

Wellgistics Health operates within the medical distribution industry, a sector characterized by increasing demand for efficient pharmaceutical supply chain solutions. The industry is driven by factors such as an aging population, rising healthcare expenditures, and the growing prevalence of chronic diseases. The competitive landscape includes established players like ALGS and smaller, specialized distributors. Wellgistics Health's focus on independent pharmacies and its DelivMeds platform position it within a niche segment of the market, offering potential for differentiation but also requiring effective execution to compete with larger, more established companies.

Key Customers

  • Independent retail pharmacies throughout the United States.
  • Small and mid-size pharmaceutical manufacturers.
  • Patients who receive prescriptions through the DelivMeds platform.
AI Confidence: 70% Updated: 2/8/2026

Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 2025 $3M -$34M $-0.46
Q2 2025 $8M -$7M $-0.11
Q1 2025 $11M -$32M $-0.62

Source: Company filings

Chart & Info

Price Chart

Wellgistics Health, Inc. (WGRX) stock price: $0.42 (-0.02, -4.24%)

Why Bull

  • •Insider buying activity suggests those in the know see long-term value, a positive signal for future growth prospects.
  • •Community sentiment is leaning bullish, with many believing the company is undervalued relative to its potential.
  • •Positive market perception is building around Wellgistics' innovative approach to healthcare solutions.
  • •Recent developments indicate potential partnerships, which could significantly expand their market reach.

Why Bear

  • •Despite insider buying, some worry about the scale of recent sales compared to purchases, raising questions about overall confidence.
  • •Bearish community views highlight concerns about increased competition in the healthcare sector.
  • •Market perception is wary of potential regulatory hurdles that could impact Wellgistics' growth trajectory.
  • •Recent developments reveal concerns about the company's ability to scale operations effectively to meet growing demand.

Latest News

Technical Analysis

RSI(14)
--
MACD
--
Volume
255,613

Rationale

AI-generated technical analysis for WGRX including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Community

Discussion

Share your analysis and discuss Wellgistics Health, Inc. (WGRX) with other investors. Log in to post.

Sentiment

Community sentiment and discussion activity for WGRX.

Make a Prediction

Set your price target for Wellgistics Health, Inc. (WGRX), choose a timeframe, and track your prediction accuracy.

Current price: $0.42

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WGRX.

Price Targets

Wall Street price target analysis for WGRX.

Insider Flow (30d)

No insider trades in the last 30 days.

MoonshotScore

43.5/100

Score Factors

  • Revenue Growth 5/100

    Revenue growth data is currently unavailable for this company.

  • Gross Margin 3/100

    Gross margin of 7.9% is below average, suggesting thin margins and potential pricing pressure.

  • Operating Leverage 4/100

    Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

  • Cash Runway 5/100

    Cash position data is currently unavailable for this company.

  • R&D Intensity 5/100

    R&D spending data is currently unavailable for this company.

  • Insider Activity 6/100

    No significant insider buying or selling recently, which is neutral for the stock outlook.

  • Short Interest 5/100

    Float and volume data unavailable for liquidity analysis.

  • Price Momentum 0/100

    No bullish technical signals detected. The stock lacks upward price momentum currently.

  • News Sentiment 5/100

    No sentiment data available

What does this score mean?

The MoonshotScore rates WGRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Frequently Asked Questions

What does Wellgistics Health, Inc. do?

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products, focusing on serving independent retail pharmacies and small to mid-size pharmaceutical manufacturers in the United States. The company distributes generic and branded pharmaceuticals, over-the-counter healthcare products, and provides third-party logistics services, including warehousing, inventory management, and shipping. Its DelivMeds platform offers a unique value proposition by facilitating prescription transfers and providing clinical concierge services to independent pharmacies, aiming to streamline operations and improve patient care.

Is WGRX stock a good buy?

WGRX stock presents a high-risk, high-reward investment opportunity. The company's negative profit margin of -1300.3% and negative P/E ratio of -0.32 raise concerns about its financial stability. However, its DelivMeds platform and focus on independent pharmacies offer potential for growth. Investors should carefully consider their risk tolerance and conduct thorough due diligence before investing. Monitoring the company's progress in achieving profitability and expanding its market share is crucial for assessing its long-term investment potential.

What are the main risks for WGRX?

The main risks for Wellgistics Health include its negative profit margin, which threatens its financial viability. Intense competition from larger pharmaceutical distributors could limit its market share and pricing power. Regulatory changes in the pharmaceutical industry could increase compliance costs and disrupt its operations. Furthermore, the company's reliance on the DelivMeds platform creates a single point of failure, and any disruption to the platform could significantly impact its business. Effective risk management and diversification of revenue streams are crucial for mitigating these risks.

Is WGRX a good stock to buy?

Whether WGRX is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.

What is the WGRX MoonshotScore?

The MoonshotScore for WGRX is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.

How often is WGRX data updated?

WGRX stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to WGRX is aggregated continuously from premium financial news sources throughout the day.

What are the growth catalysts for WGRX?

Growth catalysts for Wellgistics Health, Inc. (WGRX) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes Wellgistics Health, Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.

Who are WGRX's main competitors?

Wellgistics Health, Inc. (WGRX) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether WGRX has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.

What do analysts say about WGRX?

Wall Street analyst coverage for WGRX includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.

What is WGRX's market cap?

Market capitalization (market cap) for WGRX is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows WGRX's current market cap alongside enterprise value and other valuation metrics.

How has WGRX stock performed recently?

WGRX's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing WGRX's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.

What are the risks of investing in WGRX?

Key risk categories for WGRX include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures WGRX's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.

Are insiders buying or selling WGRX?

Insider trading activity for WGRX tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.

Is WGRX a good stock for beginners?

Wellgistics Health, Inc. (WGRX) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.

How risky is WGRX for first-time investors?

Every stock carries risk, including Wellgistics Health, Inc. (WGRX). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like WGRX.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

AI Analysis Notes
  • Financial data is limited and may not be fully representative of future performance. The company's small market capitalization and volatile stock performance increase investment risk.
Data Sources
profilefundamentalsexistingCopy